Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
43,411,663
-
Total 13F shares
-
18,582,224
-
Share change
-
-232,686
-
Total reported value
-
$216,368,968
-
Put/Call ratio
-
254%
-
Price per share
-
$11.65
-
Number of holders
-
89
-
Value change
-
-$2,774,327
-
Number of buys
-
40
-
Number of sells
-
41
Institutional Holders of Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) as of Q2 2021
As of 30 Jun 2021,
Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) was held by
89 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,582,224 shares.
The largest 10 holders included
Nantahala Capital Management, LLC, BlackRock Inc., VANGUARD GROUP INC, Corriente Advisors, LLC, Slate Path Capital LP, STATE STREET CORP, 683 Capital Management, LLC, Woodline Partners LP, Prosight Management, LP, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
89
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.